Nu Skin Enterprises, Inc. NUS
We take great care to ensure that the data presented and summarized in this overview for NU SKIN ENTERPRISES, INC. is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Top Institutions Holding NUS
View all-
Black Rock Inc. New York, NY8.35MShares$89.3 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.49MShares$69.4 Million0.0% of portfolio
-
State Street Corp Boston, MA2.04MShares$21.8 Million0.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny1.8MShares$19.2 Million0.04% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA1.39MShares$14.9 Million0.0% of portfolio
-
Morgan Stanley New York, NY1.17MShares$12.6 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA1.08MShares$11.6 Million0.0% of portfolio
-
Dimensional Fund Advisors LP Austin, TX1.07MShares$11.5 Million0.0% of portfolio
-
D. E. Shaw & Co., Inc. New York, NY981KShares$10.5 Million0.01% of portfolio
-
Aristotle Capital Boston, LLC Boston, MA812KShares$8.68 Million0.35% of portfolio
Latest Institutional Activity in NUS
Top Purchases
Top Sells
About NUS
Nu Skin Enterprises, Inc. develops and distributes beauty and wellness products worldwide. It provides skin care systems, including ageLOC Spa systems, ageLOC Transformation anti-aging skin care systems, and ageLOC LumiSpa skin treatment and cleansing devices; and ageLOC Boost, as well as a range of other cosmetic and personal care products. The company also offers ageLOC Youth nutritional supplements, ageLOC TR90 weight management and body shaping systems, LifePak nutritional supplements, ageLOC Meta nutritional supplements, and Beauty Focus Collagen+ skin care supplements, as well as other weight management products. In addition, it is involved in the research and product development of skin care products and nutritional supplements. Further, the company operates retail stores and service centers in Mainland China. It sells its products under the Nu Skin, Pharmanex, and ageLOC brands. The company promotes and sells its products directly, as well as through distributors and Website. Nu Skin Enterprises, Inc. was founded in 1984 and is headquartered in Provo, Utah.
Insider Transactions at NUS
Insider Transaction List
View all| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 12
2024
|
Edwina D Woodbury Director |
BUY
Grant, award, or other acquisition
|
Direct |
7
+0.02%
|
$91
$13.07 P/Share
|
|
Jun 07
2024
|
Zheqing Shen Director |
BUY
Grant, award, or other acquisition
|
Direct |
11,330
+25.45%
|
-
|
|
Jun 07
2024
|
Edwina D Woodbury Director |
BUY
Grant, award, or other acquisition
|
Direct |
11,330
+27.8%
|
-
|
|
Jun 07
2024
|
Laura Nathanson Director |
BUY
Grant, award, or other acquisition
|
Direct |
11,330
+34.38%
|
-
|
|
Jun 07
2024
|
Pisano R. Thomas Director |
BUY
Grant, award, or other acquisition
|
Direct |
11,330
+13.57%
|
-
|
|
Jun 07
2024
|
Daniel W Campbell Director |
BUY
Grant, award, or other acquisition
|
Direct |
11,330
+27.25%
|
-
|
|
Jun 07
2024
|
Emma S. Battle Director |
BUY
Grant, award, or other acquisition
|
Direct |
11,330
+37.08%
|
-
|
|
Jun 05
2024
|
Chayce David Clark EVP and General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
974
-0.62%
|
$12,662
$13.47 P/Share
|
|
Jun 05
2024
|
Steven Keith Hatchett Chief Product Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
459
-0.48%
|
$5,967
$13.47 P/Share
|
|
May 28
2024
|
Andrew D Lipman Director |
SELL
Open market or private sale
|
Direct |
2,000
-7.93%
|
$26,000
$13.33 P/Share
|
|
May 02
2024
|
Edwina D Woodbury Director |
SELL
Open market or private sale
|
Direct |
1,693
-8.56%
|
$20,316
$12.02 P/Share
|
|
Apr 25
2024
|
Andrew D Lipman Director |
SELL
Open market or private sale
|
Direct |
2,000
-7.35%
|
$24,000
$12.34 P/Share
|
|
Mar 25
2024
|
Andrew D Lipman Director |
SELL
Open market or private sale
|
Direct |
2,000
-6.84%
|
$24,000
$12.32 P/Share
|
|
Mar 11
2024
|
Emma S. Battle Director |
BUY
Small Acquisition
|
Direct |
17
+0.21%
|
$221
$13.1 P/Share
|
|
Mar 06
2024
|
Edwina D Woodbury Director |
BUY
Grant, award, or other acquisition
|
Direct |
8
+0.04%
|
$96
$12.82 P/Share
|
|
Feb 27
2024
|
Ryan S Napierski President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
189,574
+34.74%
|
-
|
|
Feb 27
2024
|
James D Thomas Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
43,444
+37.1%
|
-
|
|
Feb 27
2024
|
Chayce David Clark EVP and General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
69,116
+30.41%
|
-
|
|
Feb 27
2024
|
Steven Keith Hatchett Chief Product Officer |
BUY
Grant, award, or other acquisition
|
Direct |
39,495
+29.02%
|
-
|
|
Feb 26
2024
|
Andrew D Lipman Director |
SELL
Open market or private sale
|
Direct |
2,000
-6.41%
|
$24,000
$12.46 P/Share
|
Last 12 Months Summary
| Grant, award, or other acquisition | 436K shares |
|---|---|
| Small Acquisition | 155 shares |
| Open market or private sale | 46.4K shares |
|---|---|
| Payment of exercise price or tax liability | 36.4K shares |